< Back to previous page
Researcher
Kim Donckers
- Keywords:Medicine
- Disciplines:Microbiology, Systems biology, Laboratory medicine
Affiliations
- Laboratory of Virology and Chemotherapy (Rega Institute) (Division)
Member
From11 Oct 2010 → Today
Publications
1 - 6 of 6
- Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors.(2023)
Authors: Steven De Jonghe, Kim Donckers, Dirk Jochmans, Johan Neyts
Pages: eabo7201 - Nirmatrelvir-resistant SARS-CoV-2 is efficiently transmitted in female Syrian hamsters and retains partial susceptibility to treatment(2023)
Authors: Rana Abdelnabi, Dirk Jochmans, Kim Donckers, Birgit Weynand, Johan Neyts
- The Substitutions L50F, E166A, and L167F in SARS-CoV-2 3CLpro Are Selected by a Protease Inhibitor In Vitro and Confer Resistance To Nirmatrelvir(2023)
Authors: Dirk Jochmans, Kim Donckers, Bert Vanmechelen, Piet Maes, Steven De Jonghe, Johan Neyts
- A robust SARS-CoV-2 replication model in primary human epithelial cells at the air liquid interface to assess antiviral agents(2021)
Authors: Kim Donckers, Laura Vangeel, Steven De Jonghe, Johan Neyts, Dirk Jochmans
- Novel Class of Chikungunya Virus Small Molecule Inhibitors That Targets the Viral Capping Machinery(2020)
Authors: Rana Abdelnabi, Kim Donckers, Pieter Leyssen, Patrick Chaltin, Johan Neyts, Leen Delang
- Optimization of a class of tryptophan dendrimers that inhibit HIV replication leads to a selective, specific, and low-nanomolar inhibitor of clinical isolates of enterovirus A71(2016)
Authors: Liang Sun, Kim Donckers, Leen Delang, Johan Neyts, Pieter Leyssen
Pages: 5064 - 5067